ArticleJournal of medicinal chemistry2025

Accelerating the Hit-To-Lead Optimization of a SARS-CoV-2 Mpro Inhibitor Series by Combining High-Throughput Medicinal Chemistry and Computational Simulations.

Julien Hazemann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.